EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination

Ahmed Abdelhak iD, Christian Cordano, Greg J Duncan, Katie Emberley, Sonia Nocera, Wendy Xin, Kirtana Ananth, Nour Jabassini, Kiarra Ning, Henriette Reinsberg, Frederike Cosima Oertel iD, Alexandra Beaudry-Richard und 9 weitere

Brain · 01.08.2025 · 148 (8) · 3011-3020

DOI: 10.1093/brain/awaf144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 25.04.2025. Verfasst von Ahmed Abdelhak und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, CA 94158, USA. Hauptthemen laut MEDLINE: Axons, Neurofilament Proteins, Encephalomyelitis, Autoimmune, Experimental, Demyelinating Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroaxonal injury is a major driver of irreversible disability in demyelinating conditions. Accurate assessment of the association between demyelination and axonal pathology is critical for evaluating and developing effective therapeutic approaches. Measuring neurofilament light chain (NfL) in the blood could putatively allow longitudinal monitoring of neuroaxonal injury at ‘single protein resolution’ with high pathological specificity. Here, we demonstrate a robust association between blood and tissue NfL-based assessment of neuroaxonal injury and severity of inflammatory demyelination in experimental autoimmune encephalitis (EAE). In EAE, high levels of NfL were evident at the peak of demyelination and correlated with tissue evidence of NfL loss when using antibodies that target the same NfL epitopes. In addition, we validate the longitudinal NfL dynamics in relation to de- and remyelination in an inducible genetic model of inflammatory-independent myelin loss. Through inducible knockout of myelin regulatory factor (Myrf) in proteolipid protein (PLP) expressing cells in Myrffl/fl PLP1-CreERT (MyrfΔiPLP) mice, serum NfL peaked at the time of demyelination and reduced following effective remyelination. In people with multiple sclerosis, the most common demyelinating condition, we confirmed the association between NfL and myelin breakdown proteins in two independent cohorts using Olink proximity extension assays, the ReBUILD clinical trial and the multiple sclerosis participants in the UK-Biobank. Our study provides a translational framework to understand the biology behind NfL changes in the context of de- and remyelination and reveals novel aspects related to monitoring potentially reversible neuroaxonal pathology in humans and rodents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AxonsNeurofilament ProteinsEncephalomyelitis, Autoimmune, ExperimentalDemyelinating DiseasesAnimalsMiceBiomarkersFemaleHumansMice, Inbred C57BLMaleMultiple SclerosisRemyelination

Stichwörter der Autor:innen

demyelinationmultiple sclerosisneurofilament light chainneuroprotectionremyelination

Substanzen

Neurofilament ProteinsBiomarkersneurofilament protein L

Autor:innen und Institutionen

  • Department of Neurology, Weill Institute for Neurosciences, University of California at San Francisco (UCSF), San Francisco, CA 94158, USA.
  • Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Genova 16132, Italy.
  • IRCCS Ospedale Policlinico San Martino, Genova 16132, Italy.
  • Department of Neurology, Jungers Center for Neurosciences Research, Oregon Health & Science University, Portland, OR 97239, USA.
  • Max Delbrück Center, Charité-Universitätsmedizin, Berlin 13125, Germany.
  • Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, Multiple Sclerosis Centre, Neurology, University Hospital Basel and University of Basel, Basel 4031, Switzerland.

ORCID-Profile: Ahmed Abdelhak, Frederike Cosima Oertel, Jens Kuhle, Axel Petzold, Jonah R Chan

Förderung

  • NINDS NIH HHS
  • NIA NIH HHS

Zitieren

APA

Abdelhak, A., Cordano, C., Duncan, G. J., Emberley, K., Nocera, S., Xin, W., Ananth, K., Jabassini, N., Ning, K., Reinsberg, H., Oertel, F. C., Beaudry-Richard, A., Kuhle, J., Petzold, A., Patel, P. J., Ribeiro Reis, A. P., Foster, P. J., Watkins, T., Chan, J. R., …, & Green, A. J. (2025). Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination. Brain, 148(8), 3011-3020. https://doi.org/10.1093/brain/awaf144

Vancouver

Abdelhak A, Cordano C, Duncan GJ, Emberley K, Nocera S, Xin W, et al. Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination. Brain. 2025;148(8):3011-3020. doi:10.1093/brain/awaf144

BibTeX
@article{Abdelhak2025,
  author = {Abdelhak, Ahmed and Cordano, Christian and Duncan, Greg J and Emberley, Katie and Nocera, Sonia and Xin, Wendy and Ananth, Kirtana and Jabassini, Nour and Ning, Kiarra and Reinsberg, Henriette and Oertel, Frederike Cosima and Beaudry-Richard, Alexandra and Kuhle, Jens and Petzold, Axel and Patel, Praveen J and Ribeiro Reis, Ana P and Foster, Paul J and Watkins, Trent and Chan, Jonah R and Emery, Ben and Green, Ari J},
  title = {Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination},
  journal = {Brain},
  year = {2025},
  volume = {148},
  number = {8},
  pages = {3011--3020},
  doi = {10.1093/brain/awaf144}
}
Kostenlos starten →